News
Shares in Denmark's pharmaceutical giant Novo Nordisk ( NVO -4.99%) were lower by 4% as of 11 a.m. ET today. The move comes ...
Synthetic food dyes are added to 1 in 5 packaged foods and drinks sold by top U.S. food manufacturers, a new study says.
Novo Nordisk is seen as having fallen behind in the race for new obesity drugs. It argues it is playing the long game.
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.
Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical giant that is a key player in the weight loss drug market. The firm’s ...
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has recently completed a clinical study titled A ...
Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...
Despite Novo Nordisk (NVO) recently ending a partnership with Hims & Hers Health (NYSE:HIMS) to distribute its weight-loss ...
The CATALYST meta-analysis pooled the four studies and identified 5,441 people with acute ischemic stroke and Afib for inclusion. The population largely came from OPTIMAS (67%), followed by the TIMING ...
Valo Health is growing its workforce as the Boston-area biotech expands to meet the needs of its partnerships, including a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results